|
Post by sportsrancho on Apr 15, 2019 5:18:22 GMT -5
Why not Laura, does anybody make it look easier than her ?
|
|
|
Post by akemp3000 on Apr 15, 2019 6:20:03 GMT -5
Why not Laura, does anybody make it look easier than her ? And I bet she'd do it for less than a million a year Seriously, the fee should be performance based on success...as should management's and everyone else's fee.
|
|
|
Post by lennymnkd on Apr 15, 2019 6:30:33 GMT -5
Never liked the add myself/ but figured what do I know . The concenus here for years has been a somewhat intimate RESTAURANT add...
|
|
|
Post by ktim on Apr 15, 2019 6:46:23 GMT -5
You wouldn’t believe how many people have mentioned “Flo” to me and I completely agree with it! I think the reason "Flo" works, is the commercial is on many times everyday. Additionally, Flo/Progressive can be on a bill board. I have watched the commercial for years as we all have, however I do not use Progressive. Has anyone here changed to Progressive under Flo's influence?
Wonder if Flo actually uses Progressive. Also wonder how she'd work in a commercial where a majority of the time is required to be spent reciting the fine print, as is the case for FDA regulated drugs. Would have to be a very quick setup to get to a punch line before switching to fine print.
|
|
|
Post by akemp3000 on Apr 15, 2019 7:21:43 GMT -5
One thing for certain is that the Flo commercials have been highly successful otherwise these commercials would have stopped long ago even if Progressive Insurance wasn't so heavily connected to billionaire George Soros.
|
|
|
Post by uvula on Apr 15, 2019 7:59:54 GMT -5
Mnkd tried that stupid purple cartoon character that totally failed. I wonder how much we paid for that?
|
|
|
Post by ktim on Apr 15, 2019 9:45:55 GMT -5
|
|
|
Post by peppy on Apr 15, 2019 9:52:26 GMT -5
there was also the vagabond.
|
|
|
Post by cretin11 on Apr 15, 2019 11:18:34 GMT -5
I forgot about "the vagabond"! But c'mon, Dominick is an actual Afrezza user, looks like a good dude, i hope he's not on Pro Boards to see he has a nickname (or if he is, hopefully a good sense of humor)!
|
|
|
Post by uvula on Apr 15, 2019 12:10:03 GMT -5
If he is an early investor he might now actually be a vagabond.
|
|
|
Post by harryx1 on Apr 15, 2019 13:20:51 GMT -5
Why not Laura, does anybody make it look easier than her ? Here's a proposal I wrote up back in July of 2017 that I never ended up sending to MannKind and was intended to have some of the early adopters (Sam, Anthony, Laura, Laureen, Brian, Howard, etc) and potentially a CDE participate in it. I doubt they would have been receptive of the proposal though. Proposal to Conduct Public Webinars to Help New Users Titrate Afrezza Correctly BackgroundMany existing users (mostly T1Ds) may find it hard to understand the differences of dosages between inhaled insulin and subcutaneous insulin when switching to Afrezza. It’s most likely easier to grasp the dosage and timing of taking the dosage for diabetics new to insulin initiation. However, new diabetics may still have questions or perhaps may even be taught the wrong way to use Afrezza due to the long standing usage of subcutaneous insulins. We propose holding public web conferences to new patients of Afrezza with the objective of increasing their understanding of how to properly use Afrezza during mealtime. Target Audience
We believe we should target the population group of newly prescribed patients getting ready to or have just started using Afrezza. Format of the Session
We propose that the format of the session should be comprised of a PowerPoint presentation with teleconference audio. The session length would be 45-60 minutes in length and would be scheduled at strategic times (e.g. Lunch time, evening, etc. 2-3 days/week) to allow patients to participate easily. A link to a previously recorded webinar could be made available from a secure location on the corporate website for later playback on an individual basis. Personnel
Presenter, key advocate Afrezza user(s) and/or CDE Key Topics Covered
The session could be based off and closely follow the “Starting and Staying on Afrezza” guide. Towards the end of the session, a key advocate could provide personal experience on using Afrezza and help out with any questions from the audience. We propose the following topics be covered: • What is Afrezza? • Why Afrezza is different than injected insulin. o What is INsulin and OUTsulin? • Flexible Dosing Options. • How to load and use the inhaler. • Switching from injected mealtime insulin. • Premixed insulin conversion. • New to Mealtime insulin. • MannKind Cares service and support. • Tips from experienced users. • Follow up breathing tests. • FAQs. • Important Safety Information. • Audience questions answered. Delivery Options
To deliver the webinar, we recommend using a web technology platform that, at minimum, allows the presenters to control the in-meeting presentation, and enables the participants to ask questions in a text or through a moderated Q&A phone session. This provides a way for the presenters to adequately control the presentation and Q&A session, as well as reinforce Mannkind’s intent of being a professional organization. Possible webinar platforms that could be used: GoToWebinar, WebEx, Adobe Connect Platform costs range from $79-$119 per month.
|
|
|
Post by sportsrancho on Apr 15, 2019 13:25:37 GMT -5
Why not Laura, does anybody make it look easier than her ? Here's a proposal I wrote up back in July of 2017 that I never ended up sending to MannKind and was intended to have some of the early adopters (Sam, Anthony, Laura, Laureen, Brian, Howard, etc) and potentially a CDE participate in it. I doubt they would have been receptive of the proposal though. Proposal to Conduct Public Webinars to Help New Users Titrate Afrezza Correctly BackgroundMany existing users (mostly T1Ds) may find it hard to understand the differences of dosages between inhaled insulin and subcutaneous insulin when switching to Afrezza. It’s most likely easier to grasp the dosage and timing of taking the dosage for diabetics new to insulin initiation. However, new diabetics may still have questions or perhaps may even be taught the wrong way to use Afrezza due to the long standing usage of subcutaneous insulins. We propose holding public web conferences to new patients of Afrezza with the objective of increasing their understanding of how to properly use Afrezza during mealtime. Target Audience
We believe we should target the population group of newly prescribed patients getting ready to or have just started using Afrezza. Format of the Session
We propose that the format of the session should be comprised of a PowerPoint presentation with teleconference audio. The session length would be 45-60 minutes in length and would be scheduled at strategic times (e.g. Lunch time, evening, etc. 2-3 days/week) to allow patients to participate easily. A link to a previously recorded webinar could be made available from a secure location on the corporate website for later playback on an individual basis. Personnel
Presenter, key advocate Afrezza user(s) and/or CDE Key Topics Covered
The session could be based off and closely follow the “Starting and Staying on Afrezza” guide. Towards the end of the session, a key advocate could provide personal experience on using Afrezza and help out with any questions from the audience. We propose the following topics be covered: • What is Afrezza? • Why Afrezza is different than injected insulin. o What is INsulin and OUTsulin? • Flexible Dosing Options. • How to load and use the inhaler. • Switching from injected mealtime insulin. • Premixed insulin conversion. • New to Mealtime insulin. • MannKind Cares service and support. • Tips from experienced users. • Follow up breathing tests. • FAQs. • Important Safety Information. • Audience questions answered. Delivery Options
To deliver the webinar, we recommend using a web technology platform that, at minimum, allows the presenters to control the in-meeting presentation, and enables the participants to ask questions in a text or through a moderated Q&A phone session. This provides a way for the presenters to adequately control the presentation and Q&A session, as well as reinforce Mannkind’s intent of being a professional organization. Possible webinar platforms that could be used: GoToWebinar, WebEx, Adobe Connect Platform costs range from $79-$119 per month. So obviously well thought out and a great idea!!
|
|
|
Post by peppy on Apr 15, 2019 13:29:53 GMT -5
Why not Laura, does anybody make it look easier than her ? Here's a proposal I wrote up back in July of 2017 that I never ended up sending to MannKind and was intended to have some of the early adopters (Sam, Anthony, Laura, Laureen, Brian, Howard, etc) and potentially a CDE participate in it. I doubt they would have been receptive of the proposal though. Proposal to Conduct Public Webinars to Help New Users Titrate Afrezza Correctly BackgroundMany existing users (mostly T1Ds) may find it hard to understand the differences of dosages between inhaled insulin and subcutaneous insulin when switching to Afrezza. It’s most likely easier to grasp the dosage and timing of taking the dosage for diabetics new to insulin initiation. However, new diabetics may still have questions or perhaps may even be taught the wrong way to use Afrezza due to the long standing usage of subcutaneous insulins. We propose holding public web conferences to new patients of Afrezza with the objective of increasing their understanding of how to properly use Afrezza during mealtime. Target Audience
We believe we should target the population group of newly prescribed patients getting ready to or have just started using Afrezza. Format of the Session We propose that the format of the session should be comprised of a PowerPoint presentation with teleconference audio. The session length would be 45-60 minutes in length and would be scheduled at strategic times (e.g. Lunch time, evening, etc. 2-3 days/week) to allow patients to participate easily. A link to a previously recorded webinar could be made available from a secure location on the corporate website for later playback on an individual basis. Personnel Presenter, key advocate Afrezza user(s) and/or CDEKey Topics Covered
The session could be based off and closely follow the “Starting and Staying on Afrezza” guide. Towards the end of the session, a key advocate could provide personal experience on using Afrezza and help out with any questions from the audience. We propose the following topics be covered: • What is Afrezza? • Why Afrezza is different than injected insulin. o What is INsulin and OUTsulin? • Flexible Dosing Options. • How to load and use the inhaler. • Switching from injected mealtime insulin. • Premixed insulin conversion. • New to Mealtime insulin. • MannKind Cares service and support. • Tips from experienced users. • Follow up breathing tests. • FAQs. • Important Safety Information. • Audience questions answered. Delivery Options
To deliver the webinar, we recommend using a web technology platform that, at minimum, allows the presenters to control the in-meeting presentation, and enables the participants to ask questions in a text or through a moderated Q&A phone session. This provides a way for the presenters to adequately control the presentation and Q&A session, as well as reinforce Mannkind’s intent of being a professional organization. Possible webinar platforms that could be used: GoToWebinar, WebEx, Adobe Connect Platform costs range from $79-$119 per month. It has been done? (And done well. A type 1 physician that uses afrezza.) Edelman, MD and Jeremy Pettus, MD. Remember the old cigarette commercials? More endocrinologists use Afrezza? The Afrezza man?
|
|
|
Post by harryx1 on Apr 15, 2019 13:37:01 GMT -5
peppy The Afrezza Facebook group is a great resource & probably just as good if not better than a webinar.
|
|
|
Post by peppy on Apr 15, 2019 13:46:47 GMT -5
peppy The Afrezza Facebook group is a great resource & probably just as good if not better than a webinar. I Admit It, I Inhale! Inhaled & Other Newer Insulins (Jeremy Pettus, MD) is all over Afrezza Facebook group. Sam even posted under it, talking about it. Then another person just post the link again. I HAVE NO CLUE how that you tube made it to the Afrezza facebook group. www.youtube.com/watch?v=94HT41Hennk&list=PLN-L1716i5adlZPt0z6h6PVEI_9SgUj9K&index=6
|
|